| Gallium 68 PSMA-11 PET/MR imaging in patients with intermediate-or high-risk prostate cancer SY Park, C Zacharias, C Harrison, RE Fan, C Kunder, N Hatami, F Giesel, ... Radiology 288 (2), 495-505, 2018 | 128 | 2018 |
| Predicting response to immunotherapy by evaluating tumors, lymphoid cell-rich organs, and immune-related adverse events using FDG-PET/CT T Nobashi, L Baratto, SA Reddy, S Srinivas, A Toriihara, N Hatami, ... Clinical nuclear medicine 44 (4), e272-e279, 2019 | 89 | 2019 |
| Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis RH Kimura, L Wang, B Shen, L Huo, W Tummers, FV Filipp, HH Guo, ... Nature communications 10 (1), 4673, 2019 | 87 | 2019 |
| Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality I Sonni, L Baratto, S Park, N Hatami, S Srinivas, G Davidzon, SS Gambhir, ... EJNMMI physics 5, 1-12, 2018 | 64 | 2018 |
| 18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT L Baratto, SY Park, N Hatami, G Davidzon, S Srinivas, SS Gambhir, ... PloS one 12 (6), e0178936, 2017 | 58 | 2017 |
| Prospective evaluation of 18F-DCFPyL PET/CT in biochemically recurrent prostate cancer in an academic center: a focus on disease localization and changes in management H Song, C Harrison, H Duan, K Guja, N Hatami, BL Franc, F Moradi, ... Journal of Nuclear Medicine 61 (4), 546-551, 2020 | 56 | 2020 |
| PSMA-and GRPR-targeted PET: results from 50 patients with biochemically recurrent prostate cancer L Baratto, H Song, H Duan, N Hatami, HP Bagshaw, M Buyyounouski, ... Journal of Nuclear Medicine 62 (11), 1545-1549, 2021 | 52 | 2021 |
| Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine … A Toriihara, L Baratto, T Nobashi, S Park, N Hatami, G Davidzon, PL Kunz, ... European journal of nuclear medicine and molecular imaging 46, 2244-2251, 2019 | 49 | 2019 |
| Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter-and intrareader agreement A Toriihara, T Nobashi, L Baratto, H Duan, F Moradi, S Park, N Hatami, ... Journal of Nuclear Medicine 61 (4), 533-539, 2020 | 46 | 2020 |
| Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements L Baratto, H Duan, R Laudicella, A Toriihara, N Hatami, V Ferri, A Iagaru European Journal of Nuclear Medicine and Molecular Imaging 47, 115-122, 2020 | 35 | 2020 |
| 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition L Baratto, SY Park, N Hatami, P Gulaka, S Vasanawala, TK Yohannan, ... EJNMMI research 8, 1-7, 2018 | 34 | 2018 |
| Comparison between different PET and CT-based imaging interpretation criteria at interim imaging in patients with diffuse large B-cell lymphoma L Baratto, GA Davidzon, M Moghbel, N Hatami, A Iagaru, ES Mittra Clinical Nuclear Medicine 43 (1), 1-8, 2018 | 21 | 2018 |
| Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma MR Golbakhsh, B Boddouhi, N Hatami, PK Goudarzi, M Shakeri, ... Archives of Medical Science 13 (6), 1352-1356, 2017 | 15 | 2017 |
| 18F-FPPRGD2 PET/CT in patients with metastatic renal cell cancer A Toriihara, H Duan, HM Thompson, S Park, N Hatami, L Baratto, AC Fan, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 1518-1523, 2019 | 13 | 2019 |
| 18F-FSPG PET/CT Imaging of System xC– Transporter Activity in Patients with Primary and Metastatic Brain Tumors M Wardak, I Sonni, AP Fan, R Minamimoto, M Jamali, N Hatami, ... Radiology 303 (3), 620-631, 2022 | 10 | 2022 |
| Prospective evaluation in an academic center of 18F-DCFPyL PET/CT in biochemically recurrent prostate cancer: a focus on localizing disease and changes in management H Song, C Harrison, H Duan, K Guja, N Hatami, B Franc, F Moradi, ... Journal of Nuclear Medicine, 2019 | 10 | 2019 |
| Pilot study of 18F-FSPG vs18F-FDG PET imaging for response assessment in cancer S Park, N Hatami, O Rutledge, N Koglin, B Loo, A Fan, E Mittra Journal of Nuclear Medicine 58 (supplement 1), 118-118, 2017 | 10 | 2017 |
| 99mTc-MDP scintigraphy vs. 18F-NaF PET/CT for detection of skeletal metastases F Wu, M Jamali, N Hatami, I Sonni, L Baratto, HH Guo, A Quon, E Mittra, ... Journal of Nuclear Medicine 57 (supplement 2), 599-599, 2016 | 10 | 2016 |
| A pilot study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for biopsy guidance in patients with suspected prostate cancer H Duan, P Ghanouni, B Daniel, J Rosenberg, A Thong, C Kunder, ... Journal of Nuclear Medicine 64 (5), 744-750, 2023 | 9 | 2023 |
| Pilot-phase PET/CT study targeting integrin αvβ6 in pancreatic cancer patients using the cystine-knot peptide–based 18F-FP-R01-MG-F2 R Nakamoto, V Ferri, H Duan, N Hatami, M Goel, J Rosenberg, R Kimura, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-10, 2022 | 9 | 2022 |
